RecruitingNCT05849155

Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition


Sponsor

St. Jude Children's Research Hospital

Enrollment

125 participants

Start Date

Dec 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are often unsure about talking with their CAYA about their genetic risk for cancer. By understanding how parents communicate with their CAYA, the investigators can improve future genetic education to reduce cancer risk. Primary Objectives: * Identify qualities of parent-CAYA (child, adolescent, and young adults) communication about CAYAs' genomic cancer risk, and their association with CAYAs' psychosocial and prevention outcomes. * Examine the association between sociodemographic, cancer-related, and psychosocial factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer. * Identify barriers and facilitators of parent-CAYA communication regarding CAYAs' genomic risk for cancer.


Eligibility

Min Age: 10 YearsMax Age: 24 Years

Plain Language Summary

Simplified for easier understanding

This study examines how parents and children with cancer predisposition syndromes communicate about genetic risk. Children who carry inherited mutations in cancer predisposition genes — variants that significantly increase their lifetime risk of developing certain cancers — face unique psychological challenges, as do their parents who must decide how and when to share this information, and how to support their child emotionally while managing their own anxiety. Understanding the barriers and facilitators to these crucial conversations can help healthcare providers better support families navigating this difficult situation. Eligible participants must be patients aged 10 to 24 years who have undergone germline genetic testing and carry a pathogenic or likely pathogenic variant in a known cancer predisposition gene, with the result already disclosed to them. They must have a primary caregiver willing to participate alongside them, and both patient and caregiver must be able to speak and read English. Children who are only carriers of recessive variants without elevated cancer risk, or those with significant cognitive deficits, medical conditions precluding participation, or whose caregivers are under 18 are excluded. Participants will complete surveys and potentially interviews about their communication experiences, concerns, and support needs. This research matters because for a child to grow up knowing they carry a hereditary cancer risk is a profound psychological burden — and the quality of parent-child communication about this risk can either buffer or amplify that burden. Better guidance for families could reduce anxiety, improve adherence to cancer surveillance, and ultimately save lives through earlier cancer detection.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

St. Jude Children's Research Hospital

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05849155


Related Trials